In the Psoriatic Arthritis Drug Market, Abbott/Eisai's Humira Will Displace …
The upcoming Pharmacor advisory service entitled Psoriatic Arthritis, which will be published soon, finds that the TNF-alpha inhibitor etanercept (Amgen/Pfizer/Takeda's Enbrel) was the 2011 market leader, leading by a small margin over adalimumab …
Full News here – Read more on MarketWatch (press release)
In the Psoriatic Arthritis Drug Market, Abbott/Eisai's Humira Will Displace …
Posted on 23 December 2012.
Leave a Reply
-
58 Fans Like
-
1,232 Followers Follow
-
0 Subscribers Subscribe
- Covidien's lung cancer detection system included in ACCP guidelines
- Hemolytic Anemia after mitral valve repair: a case report – 7thSpace
- Shock your penis into action!
- 10 Investigates: Mother May Have Faked Claims Of Son's Cancer
- Study: Staying fit cuts cancer death risk in middle age
- lasik
-
CT scan (3/13) – Medical Informer Video
-
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video
-
Aspirin Toner – Medical Informer Video
-
Animation about diabetes and the body. – Medical Informer Video
-
matheus Henrique: putis e muito bom sobre esse ai karanho ...
-
flaviodonato: Bem bacana esclarecimento. Fico bem feliz quando ...
-
ItsMasterBTB: ok then...
-
therugburnz: I did a search for "bad music' and this is no...
-
thetwinkleturnip: that is exactly what I did!!!...
Stay up to date
- Subscribe to the RSS feed
- Subscribe to the feed via email
